Medical Information Only: This medication is not sold on this site. The information provided is for reference purposes only. Please consult your local physician or pharmacist for treatment.
Bilignostum: Full Drug Profile
Medically reviewed by Min Clinic Staff | Updated: January 2026
Bilignostum - General Information
A water-soluble radiographic contrast media for cholecystography and intravenous cholangiography.
Pharmacology of Bilignostum
Not Available
Additional information about Bilignostum
- Bilignostum Indication
Used as a contrast agent for cholecystography and intravenous cholangiography.
- Mechanism Of Action
- Organic iodine compounds block x-rays as they pass through the body, thereby allowing body structures containing iodine to be delineated in contrast to those structures that do not contain iodine. The degree of opacity produced by these iodinated organic compounds is directly proportional to the total amount (concentration and volume) of the iodinated contrast agent in the path of the x-rays. Bilignostum's primary excretion through the hepato-biliary system and concentration in bile allows visualization of the gallbladder and biliary ducts.
- Generic Name
- Iodipamide
- Synonyms
- 3,3'-[(1,6-dioxohexane-1,6-diyl)diimino]bis(2,4,6-triiodobenzoic acid); Iodipamic acid; Adipiodone; Adipiodonum [INN-Latin]; Adipiodona [INN-Spanish]; IDB
- Drug Category
- Contrast Media
- Drug Type
- Small Molecule; Approved
- Other Brand Names containing Iodipamide
- Transbilix; Cholospect; Cholografin; Biligrafin; Bilignostum; Bilignost;
- Toxicity (Overdose)
- Acute IV LD50 is 5000 mg/kg in rat, 3195 mg/kg in mouse, and 1200 mg/kg in dog.
- Biotransformation
- Hepatic.
- Dosage Forms of Bilignostum
- Injection, solution Intravenous drip
- Chemical IUPAC Name
- 3-[[6-[(3-carboxy-2,4,6-triiodophenyl)amino]-6-oxohexanoyl]amino]-2,4,6-triiodobenzoic acid
- Chemical Formula
- C20H14I6N2O6
- Organisms Affected
- Humans and other mammals
